Vero-Spironolactone

Vero-Spironolactone: instructions for use, indications, contraindications and side effects

Vero-Spironolactone is a drug that belongs to the group of potassium-sparing diuretics. Its international name is Spironolactone. The drug is produced by Veropharm and the Belgorod branch in Russia.

The use of Vero-Spironolactone is recommended in cases of primary hyperaldosteronism, aldosterone-producing adrenal adenoma, edema syndrome against the background of secondary hyperaldosteronism in chronic heart failure, liver cirrhosis (with ascites or edema), nephrotic syndrome. The drug is also used for the treatment of arterial hypertension due to secondary hyperaldosteronism, some forms of essential hypertension, hypokalemia, including during therapy with saluretics and digitalis preparations, edema and nephropathy in pregnant women, edematous syndrome in newborns, infectious-allergic bronchial asthma (especially complicated by right-sided heart failure ), myopathy, myasthenia gravis, parkinsonism, polycystic ovary syndrome (prevention and treatment), hirsutism (treatment), premenstrual syndrome, premature puberty in young men and bronchopulmonary dysplasia.

Contraindications to the use of Vero-Spironolactone include hypersensitivity to its components, hyperkalemia, azotemia, anuria, acute or chronic renal failure with significant impairment of excretory function, including chronic nephritis in the nephrotic stage.

When using Vero-Spironolactone, side effects may occur, such as hyperkalemia, hyponatremia, increased blood concentrations of urea, creatinine, uric acid, disturbances of water-salt metabolism and acid-base balance (metabolic hyperchloremic acidosis or alkalosis), nausea, vomiting, dyspeptic symptoms, pain in the abdomen, intestinal motility disorders, diarrhea or constipation, intestinal colic, gastritis, ulcerations and bleeding in the gastrointestinal tract, headache, dizziness, ataxia, drowsiness, mental disorders, muscle spasms, gynecomastia, erectile dysfunction, in rare cases - allergic reactions, including anaphylactic shock.

The dosage of Vero-Spironolactone and the duration of its use depend on the specific pathology and condition of the patient. Typically, the starting dose for adults is 25-100 mg per day, divided into 1-2 doses. The maximum dose is 400 mg per day. For children, the use of Vero-Spironolactone is possible only under strict indications and under the supervision of a physician.

Before starting to use Vero-Spironolactone, you must consult your doctor and strictly follow his prescription. Self-medication with this drug may be hazardous to your health.